Author
Listed:
- Md. Sadikuj Jaman
(University of Rajshahi-6205, Bangladesh)
- Abdullah Al Mamun
(Hajee Mohammed Danesh Science and Technology, Bangladesh)
- Bishal Sharker
(Hajee Mohammed Danesh Science and Technology, Bangladesh)
- Md. Maniruzzaman
(Varendra University, Bangladesh)
- Md. Rakib Rased Rana
(Varendra University, Bangladesh)
- Md. Nahid Hasan
(Bangladesh University of Health Science, Bangladesh)
- Md. Rokibul Hasan Bhuiyan
(University of Rajshahi-6205, Bangladesh)
Abstract
Globally, Breast cancer is a complex and common disease. 12.5 % of all new annual cancer cases worldwide. In 2020 there were 2.3 million women with breast cancer diagnosed and 685,000 died globally. For long time, breast cancer treatments options include surgery, chemotherapy, hormone therapy and radiotherapy. However adverse effects from treatment options are frequently reported and multidrug resistance, fever, weakness, allergy and the absence of treatment for metastasis are the main issues with breast cancer treatment. Due to their safety, dietary bioactive molecules have become effective tools for the treatment and prevention of cancer cell lines and animal models in recent years. It has been demonstrated that the compunds curcumin, diallyl sulfide, quercetin and gallic acid which are used as Indian spice and widely consumed fruits, suppress the growth of breast cancer cells and trigger apoptosis. The effects of curcumin, diallyl sulfide, quercetin and gallic acid in the combat against breast cancer are covered in this review. These agents have been shown to have effects both in vitro and in vivo.
Suggested Citation
Md. Sadikuj Jaman & Abdullah Al Mamun & Bishal Sharker & Md. Maniruzzaman & Md. Rakib Rased Rana & Md. Nahid Hasan & Md. Rokibul Hasan Bhuiyan, 2023.
"Curcumin, Diallyl Sulphide, Quercetin and Gallic Acid Uses as Anticancer and Therapeutic Agents for Breast Cancer: Current Strategies and Future Perspectives,"
European Journal of Medical and Health Sciences, European Open Science, vol. 5(3), pages 32-48, April.
Handle:
RePEc:epw:ejmed0:v:5:y:2023:i:3:id:41699
DOI: 10.24018/ejmed.2023.5.3.1699
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:5:y:2023:i:3:id:41699. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.